Allelic Imbalance of 12q22–23 Associated with APAF-1 Locus Correlates with Poor Disease Outcome in Cutaneous Melanoma
暂无分享,去创建一个
D. Elashoff | D. Morton | D. Hoon | B. Taback | A. Fujimoto | H. Takeuchi | E. Hsueh
[1] R. Schlegel,et al. Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer , 2003, Molecular pathology : MP.
[2] G. Pfeifer,et al. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. , 2003, Cancer research.
[3] Petr Pancoska,et al. p53 has a direct apoptogenic role at the mitochondria. , 2003, Molecular cell.
[4] D. Morton,et al. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. , 2003, Cancer research.
[5] W. Scott. Visualizing the structure and mechanism of a small nucleolytic ribozyme. , 2002, Methods.
[6] D. Hoon,et al. Assessment of genetic heterogeneity in tumors using laser capture microdissection. , 2002, Methods in enzymology.
[7] P. Hersey,et al. How melanoma cells evade trail-induced apoptosis , 2001, Nature Reviews Cancer.
[8] M. Takata,et al. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. , 2001, Cancer research.
[9] David S. Park,et al. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death , 2001, The Journal of cell biology.
[10] C. Harris,et al. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. , 2001, Cancer research.
[11] K. Helin,et al. Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.
[12] M. Herlyn,et al. No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma. , 2001, Trends in molecular medicine.
[13] R. Turner,et al. Molecular clonality of in-transit melanoma metastasis. , 2001, The American journal of pathology.
[14] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[15] Y. Lazebnik,et al. Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. , 2000, Blood.
[16] T. Furukawa,et al. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma , 2000, American Journal of Gastroenterology.
[17] R. Elashoff,et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. , 2000, Cancer research.
[18] M. Takata,et al. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis. , 2000, International journal of cancer.
[19] R. Elashoff,et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] R. Kucherlapati,et al. A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors. , 1999, Genome research.
[21] M. Takata,et al. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma , 1999, Oncogene.
[22] M. Takata,et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. , 1998, The Journal of investigative dermatology.
[23] T. Furukawa,et al. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. , 1998, Cancer research.
[24] E. Healy,et al. Prognostic significance of allelic losses in primary melanoma , 1998, Oncogene.
[25] R. Chaganti,et al. A genetic perspective of male germ cell tumors. , 1998, Seminars in oncology.
[26] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[27] J. Yokota,et al. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. , 1997, British Journal of Cancer.
[28] A. Olek,et al. A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.
[29] A. Horii,et al. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1‐cM region of common allelic loss , 1996, Genes, chromosomes & cancer.
[30] R. Kucherlapati,et al. Physical mapping of a commonly deleted region, the site of a candidate tumor suppressor gene, at 12q22 in human male germ cell tumors. , 1996, Genomics.
[31] A. Hartmann,et al. Overexpression and mutations of p53 in metastatic malignant melanomas , 1996, International journal of cancer.
[32] B. Iacopetta,et al. p53 gene mutation and expression in naevi and melanomas , 1995, Melanoma research.
[33] E. Healy,et al. Loss of heterozygosity in sporadic primary cutaneous melanoma , 1995, Genes, chromosomes & cancer.
[34] N. Hayward,et al. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma , 1994, International journal of cancer.
[35] N. Hayward,et al. Mutation and expression of the p53 gene in human malignant melanoma , 1994, Melanoma research.
[36] J. Trent,et al. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. , 1991, Cancer research.